Oncolytics Biotech Inc. (ONCY) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oncolytics Biotech Inc.

    NASDAQ: ONCY · Real-Time Price · USD
    1.38
    -0.04 (-2.82%)
    At close: Oct 03, 2025, 3:59 PM
    1.43
    3.62%
    After-hours: Oct 03, 2025, 07:54 PM EDT

    Oncolytics Biotech Ratios and Metrics

    Financials in CAD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -3.17 -4.26 -5.16 -3.57
    PEG Ratio
    		 n/a 0.92 0.42 -1.72
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 16.80 4.29 4.83 2.60
    P/FCF Ratio
    		 -3.69 -4.15 -5.47 -4.14
    P/OCF Ratio
    		 -3.73 -4.15 -5.48 -4.19
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.18 0.02 0.01 0.02
    Quick Ratio
    		 2.82 9.01 9.05 16.69
    Current Ratio
    		 2.82 9.01 9.05 16.69
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -54.11 n/a
    Return on Equity
    		 -5.3 -1.01 -0.94 -0.73
    Return on Assets
    		 -1.57 -0.71 -0.67 -0.57
    Return on Invested Capital
    		 -2.55 -0.98 -0.85 -0.6
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist